Michael Mina (epidemiologist)

Michael Mina
Born
Michael Joseph Mina
Alma materDartmouth College
Emory University
Scientific career
FieldsEpidemiology, Ecology, Evolutionary biology, Genetics, Clinical pathology
Institutions
ThesisCross-kingdom effects of a live attenuated viral vaccine on dynamics of and disease due to respiratory pathogens within divergent ecological domains: Introducing the generalized herd effect (2014)
Doctoral advisorKeith P. Klugman

Michael Joseph Mina is an American epidemiologist, immunologist and physician. He was formerly an assistant professor of Epidemiology & Immunology and Infectious Diseases at Harvard T.H. Chan School of Public Health, assistant Professor of Pathology at Brigham and Women's Hospital, Harvard Medical School,[1] and currently Chief Medical Officer at eMed.[2] and Chief Medical and Science Officer at Oncodea.

Mina is notable for his promotion of using rapid antigen tests to halt or slow the COVID-19 pandemic.[3]

  1. ^ Mandavilli, Apoorva (29 August 2020). "Your Coronavirus Test Is Positive. Maybe It Shouldn't Be". The New York Times. Retrieved 8 February 2021.
  2. ^ Krueger, Hanna (22 December 2021). "Michael Mina can't stop talking about the need for rapid COVID tests. The country may finally be listening. But is it too late?". Boston Globe. Retrieved 29 December 2021.
  3. ^ Kotlikoff, Laurence; Mina, Michael (3 July 2020). "A Cheap, Simple Way to Control the Coronavirus". The New York Times. Retrieved 8 February 2021.